Shorts are fooling themselves. And now another nail being driven into their coffins.
No shares to cover, a billionaire that has bought over 50m of stock on a 400m market cap company in the last year, and a drug which restaged inoperable breast cancer allowing for a removal of tumor. This drug works. Period. And shorts are in for a ride when this breaks to the upside beyond 10.
Oh, and the drug restaged the patient's cancer as a MONOTHERAPY. Note that when the drug goes through Phase 3 for FDA approval, it will not be pushed as a monotherapy, but in conjunction with a known cancer drug. The chances of approval will be even higher given that such an impressive result was seen in monotherapy. And there are more success stories to come.